Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-09-28FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine (generic) filed by Chartwell Governmental & Specialty RX, LLC. The approval confirms …
-
FDA approval · 2009-08-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, enabling the generic prod…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder [NA]
A completed clinical trial explored adding an NMDA receptor agonist to exposure therapy for Panic Disorder to improve treatment outcomes.
-
FDA approval · 2009-08-21FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for generic fluoxetine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Study Evaluating Venlafaxine ER in Patients With Panic Disorder [Phase 3]
A Phase 3 trial evaluating venlafaxine extended-release for panic disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Study Evaluating Venlafaxine ER in Adults With Panic Disorder [Phase 3]
A Phase 3 trial evaluating venlafaxine ER for panic disorder in adults has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Aripiprazole for the Treatment of Refractory Anxiety [Phase 4]
Phase 4 clinical trial update evaluating aripiprazole for treatment-refractory anxiety, including generalized anxiety disorder and panic dis…
-
FDA approval · 2009-08-07FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride).
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Therapies for Treatment-Resistant Panic Disorder Symptoms [Phase 2, Phase 3]
A completed Phase 2/3 trial update evaluating therapies for treatment-resistant panic disorder symptoms. Results were posted in 2009.
-
FDA approval · 2009-07-22FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690, authorizing …
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder [NA]
Clinical trial update noting the completion of a study addressing help-seeking barriers in developing an intensive treatment for veterans wi…
-
FDA approval · 2009-05-07FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for clonazepam submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2009-04-23FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental NDA for KLONOPIN (clonazepam) submitted by H2-Pharma, LLC.
-
FDA approval · 2009-04-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc., indicating approval of a modificati…
-
FDA approval · 2009-04-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited, approving changes related to th…
-
FDA label_change · 2009-03-30FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Fluoxetine from Teva Pharmaceuticals USA, Inc., updating the labeling of the approved product.
-
FDA approval · 2009-03-19FDA Approved: FLUOXETINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original ANDA for fluoxetine from Alembic Pharmaceuticals Limited, enabling a generic version of fluoxetine to be marketed.
-
FDA approval · 2009-03-19FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Fluoxetine by Aurobindo Pharma Limited, enabling a generic Fluoxetine product. The approved indica…
-
FDA approval · 2009-03-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited. This approval authorizes a gene…
-
FDA approval · 2009-02-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, a generic version of the antidepressant …
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder [Phase 3]
A Phase 3 trial comparing internet-based cognitive behavioral therapy to group-administered CBT for panic disorder has completed.
-
FDA approval · 2009-01-30FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by ROERIG.
-
FDA approval · 2009-01-30FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE from Apotex Corp.
-
FDA approval · 2009-01-30FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride), authorizing a generic version under the exist…
-
FDA approval · 2009-01-30FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approves a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.